Summary
| Name | KAT5View Modifications |
| Full Name | Histone acetyltransferase KAT5 |
| Synonyms | 60 kDa Tat-interactive protein, Tip60, Histone acetyltransferase HTATIP, HIV-1 Tat interactive protein, Lysine acetyltransferase 5, cPLA(2)-interacting protein | HTATIP, TIP60 |
| Primary ID | Q92993 |
| Links | - - ![]() |
| Type | protein |
| Relations | 19 |
| Pathways | Acute Myeloid Leukemia, IDH-TET in AML |
| Function | Catalytic subunit of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A (PubMed:12776177, PubMed:15042092, PubMed:15121871, PubMed:15310756, PubMed:14966270, PubMed:16387653, PubMed:19909775, PubMed:15196461). This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription (PubMed:12776177, PubMed:15042092, PubMed:15121871, PubMed:15310756, PubMed:14966270, PubMed:15196461). This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair (PubMed:15196461). NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage (PubMed:15196461). Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome (PubMed:24463511). Also acetylates non-histone proteins, such as ATM, NR1D2, RAN, FOXP3, ULK1 and RUBCNL/Pacer (PubMed:16141325, PubMed:17360565, PubMed:17996965, PubMed:29040603, PubMed:30704899). Directly acetylates and activates ATM (PubMed:16141325). Relieves NR1D2-mediated inhibition of APOC3 expression by acetylating NR1D2 (PubMed:17996965). Promotes FOXP3 acetylation and positively regulates its transcriptional repressor activity (PubMed:17360565). Acetylates RAN at 'Lys-134' (PubMed:29040603). Together with GSK3 (GSK3A or GSK3B), acts as a regulator of autophagy |
Viewer
Search Tools
Refine search:
- by mechanism
- by effect
- by organism:
- by tissue:
- by cell-line
Modifications Tables
Relations
| Regulator | Mechanism | target | score ℹ | |
|---|---|---|---|---|
| + | KAT5 | down-regulates
acetylation
|
NOTCH1 | 0.414 |
| Publications: | 4 | Organism: | Homo Sapiens | |
| Pathways: | Acute Myeloid Leukemia | |||
| + | KAT5 | down-regulates activity
acetylation
|
H4C1 | 0.2 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | KAT5 | up-regulates activity
acetylation
|
CHKA | 0.2 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | KAT5 | up-regulates activity
acetylation
|
ATM | 0.801 |
| Publications: | 1 | |||
| + | KAT5 | down-regulates
acetylation
|
SRSF2 | 0.468 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| Pathways: | Acute Myeloid Leukemia, IDH-TET in AML | |||
| + | CyclinB/CDK1 | up-regulates activity
phosphorylation
|
KAT5 | 0.418 |
| Publications: | 2 | Organism: | Homo Sapiens | |
| + | GSK3B | up-regulates
phosphorylation
|
KAT5 | 0.369 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| Pathways: | Acute Myeloid Leukemia | |||
| + | CDK1 | up-regulates
phosphorylation
|
KAT5 | 0.479 |
| Publications: | 2 | Organism: | Homo Sapiens | |
| Pathways: | Acute Myeloid Leukemia, IDH-TET in AML | |||
| + | MAPK14 | up-regulates activity
phosphorylation
|
KAT5 | 0.322 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | ABL1 | down-regulates activity
phosphorylation
|
KAT5 | 0.647 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | KAT5 | up-regulates activity
binding
|
MYOD1 | 0.365 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | PRKCE | up-regulates activity
phosphorylation
|
KAT5 | 0.365 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | KAT5 | form complex
binding
|
NuA4 complex | 0.781 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| + | MDM2 | down-regulates quantity by destabilization
polyubiquitination
|
KAT5 | 0.653 |
| Publications: | 1 | Organism: | Homo Sapiens | |
| Pathways: | Acute Myeloid Leukemia, IDH-TET in AML | |||
4.0
KAT5


acetylation
acetylation
binding